Pernix Therapeutics Holdings Inc. (PTX) News Nov 2
Post# of 250601
Posted On: 11/20/2014 11:56:13 PM
Pernix Therapeutics Holdings Inc. (PTX) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on PTX
Mid-caps hesitate at major resistance 11:29 a.m. Nov. 14, 2014 - Michael Ashbaugh
6 stocks to watch 3:38 p.m. Nov. 12, 2014 - The Trading Deck
6 stocks to watch 2:56 p.m. June 18, 2014 - The Trading Deck
Charting a bullish June technical backdrop 11:21 a.m. June 17, 2014 - Michael Ashbaugh
Charting a bullish June technical backdrop 11:06 a.m. June 17, 2014 - Michael Ashbaugh
Major U.S. benchmarks approach bull-bear tipping point 11:01 a.m. May 20, 2014 - Michael Ashbaugh
Major U.S. benchmarks approach bull-bear tipping point 10:40 a.m. May 20, 2014 - Michael Ashbaugh
Tuesday’s biggest gaining & declining stocks 4:53 p.m. Aug. 16, 2011 - Kate Gibson
Updates, advisories and surprises 4:01 p.m. May 17, 2011 - MarketWatch
Tuesday’s biggest gaining and declining stocks 2:08 p.m. May 17, 2011 - Greg Morcroft
Pernix leads drug stocks south 12:31 p.m. May 17, 2011 - Val Brickates Kennedy
Pernix tumbles 20% folllowing earnings report 9:06 a.m. May 17, 2011 - Val Brickates Kennedy
Other News on PTX
Expect More Specialty Pharma Deals 7:41 a.m. Nov. 14, 2014 - Barrons.com
10-Q: PERNIX THERAPEUTICS HOLDINGS, INC. 5:13 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Pernix Therapeutics Holdings' (PTX) CEO Douglas Drysdale on Q3 2014 Results - Earnings Call Transcript 3:46 p.m. Nov. 10, 2014 - Seeking Alpha
Pernix Therapeutics ups revenues 72% in Q3 1:15 p.m. Nov. 10, 2014 - Seeking Alpha
Pernix Therapeutics Holdings (PTX) Q3 2014 Results - Earnings Call Webcast 9:55 a.m. Nov. 10, 2014 - Seeking Alpha
Pernix acquires U.S. rights to Treximet 8:03 a.m. Aug. 20, 2014 - Seeking Alpha
10-Q: PERNIX THERAPEUTICS HOLDINGS, INC. 3:43 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Pernix Therapeutics Holdings (PTX) CEO Doug Drysdale on Q2 2014 Results - Earnings Call Transcript 3:36 p.m. Aug. 11, 2014 - Seeking Alpha
Pernix Therapeutics Holdings (PTX) Q2 2014 Results - Earnings Call Webcast 8:55 a.m. Aug. 11, 2014 - Seeking Alpha
Pernix effort to acquire rights to Treximet hits a snag 9:53 a.m. Aug. 4, 2014 - Seeking Alpha
How Doctor Got Rich Invoking Antifraud Law 10:39 a.m. July 24, 2014 - The Wall Street Journal Interactive Edition
GSK Keen to Keep Some Emerging Markets Drugs 10:35 a.m. May 30, 2014 - TheStreet.com
Why Pernix Therapeutics (PTX) Is Higher This Morning 9:14 a.m. May 15, 2014 - TheStreet.com
Why Pernix Therapeutics (PTX) Soared to a One-Year High Today 11:09 a.m. May 14, 2014 - TheStreet.com
Pernix acquires U.S. rights to Treximet 7:18 a.m. May 14, 2014 - Seeking Alpha
Pernix Therapeutics Holdings' CEO Discusses Q1 2014 Results - Earnings Call Transcript 3:19 p.m. May 12, 2014 - Seeking Alpha
Pernix Therapeutics Holdings (PTX) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. May 12, 2014 - Seeking Alpha
10-K: PERNIX THERAPEUTICS HOLDINGS, INC. 3:50 p.m. March 17, 2014 - Edgar Online - (EDG = 10Q, 10K)
Pernix Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:53 a.m. March 17, 2014 - Seeking Alpha
Pernix Therapeutics Holdings, Inc. Discusses Q4 2013 Results (Webcast) 7:55 a.m. March 17, 2014 - Seeking Alpha
Press Releases on PTX
Pernix Submits sNDA for TREXIMET® Use in Adolescent Patients 7:39 a.m. Nov. 17, 2014 - BusinessWire - BZX
Pernix Therapeutics Reports Third Quarter 2014 Financial Results and Reaffirms Guidance 8:02 a.m. Nov. 10, 2014 - BusinessWire - BZX
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Pernix Therapeutics to Report Q3 2014 Financial Results 7:46 a.m. Oct. 27, 2014 - BusinessWire - BZX
Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance. 7:02 a.m. Aug. 20, 2014 - BusinessWire - BZX
POZEN Announces U.S. Rights For TREXIMET® Have Been Acquired by Pernix Therapeutics 7:01 a.m. Aug. 20, 2014 - BusinessWire - BZX
Pernix Therapeutics Reports Second Quarter 2014 Financial Results 7:31 a.m. Aug. 11, 2014 - BusinessWire - BZX
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Closing for Pernix Transaction to Acquire Treximet® Tablets for Migraine from GSK Delayed 8:15 a.m. Aug. 4, 2014 - BusinessWire - BZX
Pernix Therapeutics to Report Second Quarter 2014 Financial Results on August 11, 2014 8:01 a.m. July 25, 2014 - BusinessWire - BZX
Gyrotron Technology Inc. Elects Jan H. Loeb to Its Board of Directors 2:11 p.m. July 22, 2014 - Marketwire
Agreements, Orphan Drug Designations, and Management Changes - Analyst Notes on Medtronic, DARA BioSciences, Sequenom, AcelRx and Pernix 4:20 a.m. June 19, 2014 - PR Newswire - PRF
Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma 6:10 a.m. June 16, 2014 - PR Newswire - PRF
Technical Analysis on Equities Reaching New Highs -- Research on Kroger, SBA Communications, SunOpta, and Pernix Therapeutics 9:43 a.m. May 15, 2014 - PR Newswire - PRF
PERNIX Signs Agreement to Acquire TREXIMET® Tablets for Migraine From GSK 6:31 a.m. May 14, 2014 - BusinessWire - BZX
POZEN Announces U.S. Rights for Treximet® to Be Acquired by Pernix Therapeutics 6:31 a.m. May 14, 2014 - BusinessWire - BZX
Pernix Therapeutics to Report First Quarter 2014 Financial Results on May 12, 2014 8:06 a.m. May 12, 2014 - BusinessWire - BZX
Pernix Therapeutics Reports First Quarter 2014 Financial Results 7:32 a.m. May 12, 2014 - BusinessWire - BZX
Pernix Therapeutics Appoints Tasos Konidaris to Its Board of Directors 7:46 a.m. April 28, 2014 - BusinessWire - BZX
Pernix Closes on Sale of Manufacturing Facility 7:46 a.m. April 25, 2014 - BusinessWire - BZX
MarketWatch News on PTX
Mid-caps hesitate at major resistance 11:29 a.m. Nov. 14, 2014 - Michael Ashbaugh
6 stocks to watch 3:38 p.m. Nov. 12, 2014 - The Trading Deck
6 stocks to watch 2:56 p.m. June 18, 2014 - The Trading Deck
Charting a bullish June technical backdrop 11:21 a.m. June 17, 2014 - Michael Ashbaugh
Charting a bullish June technical backdrop 11:06 a.m. June 17, 2014 - Michael Ashbaugh
Major U.S. benchmarks approach bull-bear tipping point 11:01 a.m. May 20, 2014 - Michael Ashbaugh
Major U.S. benchmarks approach bull-bear tipping point 10:40 a.m. May 20, 2014 - Michael Ashbaugh
Tuesday’s biggest gaining & declining stocks 4:53 p.m. Aug. 16, 2011 - Kate Gibson
Updates, advisories and surprises 4:01 p.m. May 17, 2011 - MarketWatch
Tuesday’s biggest gaining and declining stocks 2:08 p.m. May 17, 2011 - Greg Morcroft
Pernix leads drug stocks south 12:31 p.m. May 17, 2011 - Val Brickates Kennedy
Pernix tumbles 20% folllowing earnings report 9:06 a.m. May 17, 2011 - Val Brickates Kennedy
Other News on PTX
Expect More Specialty Pharma Deals 7:41 a.m. Nov. 14, 2014 - Barrons.com
10-Q: PERNIX THERAPEUTICS HOLDINGS, INC. 5:13 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Pernix Therapeutics Holdings' (PTX) CEO Douglas Drysdale on Q3 2014 Results - Earnings Call Transcript 3:46 p.m. Nov. 10, 2014 - Seeking Alpha
Pernix Therapeutics ups revenues 72% in Q3 1:15 p.m. Nov. 10, 2014 - Seeking Alpha
Pernix Therapeutics Holdings (PTX) Q3 2014 Results - Earnings Call Webcast 9:55 a.m. Nov. 10, 2014 - Seeking Alpha
Pernix acquires U.S. rights to Treximet 8:03 a.m. Aug. 20, 2014 - Seeking Alpha
10-Q: PERNIX THERAPEUTICS HOLDINGS, INC. 3:43 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Pernix Therapeutics Holdings (PTX) CEO Doug Drysdale on Q2 2014 Results - Earnings Call Transcript 3:36 p.m. Aug. 11, 2014 - Seeking Alpha
Pernix Therapeutics Holdings (PTX) Q2 2014 Results - Earnings Call Webcast 8:55 a.m. Aug. 11, 2014 - Seeking Alpha
Pernix effort to acquire rights to Treximet hits a snag 9:53 a.m. Aug. 4, 2014 - Seeking Alpha
How Doctor Got Rich Invoking Antifraud Law 10:39 a.m. July 24, 2014 - The Wall Street Journal Interactive Edition
GSK Keen to Keep Some Emerging Markets Drugs 10:35 a.m. May 30, 2014 - TheStreet.com
Why Pernix Therapeutics (PTX) Is Higher This Morning 9:14 a.m. May 15, 2014 - TheStreet.com
Why Pernix Therapeutics (PTX) Soared to a One-Year High Today 11:09 a.m. May 14, 2014 - TheStreet.com
Pernix acquires U.S. rights to Treximet 7:18 a.m. May 14, 2014 - Seeking Alpha
Pernix Therapeutics Holdings' CEO Discusses Q1 2014 Results - Earnings Call Transcript 3:19 p.m. May 12, 2014 - Seeking Alpha
Pernix Therapeutics Holdings (PTX) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. May 12, 2014 - Seeking Alpha
10-K: PERNIX THERAPEUTICS HOLDINGS, INC. 3:50 p.m. March 17, 2014 - Edgar Online - (EDG = 10Q, 10K)
Pernix Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:53 a.m. March 17, 2014 - Seeking Alpha
Pernix Therapeutics Holdings, Inc. Discusses Q4 2013 Results (Webcast) 7:55 a.m. March 17, 2014 - Seeking Alpha
Press Releases on PTX
Pernix Submits sNDA for TREXIMET® Use in Adolescent Patients 7:39 a.m. Nov. 17, 2014 - BusinessWire - BZX
Pernix Therapeutics Reports Third Quarter 2014 Financial Results and Reaffirms Guidance 8:02 a.m. Nov. 10, 2014 - BusinessWire - BZX
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Pernix Therapeutics to Report Q3 2014 Financial Results 7:46 a.m. Oct. 27, 2014 - BusinessWire - BZX
Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance. 7:02 a.m. Aug. 20, 2014 - BusinessWire - BZX
POZEN Announces U.S. Rights For TREXIMET® Have Been Acquired by Pernix Therapeutics 7:01 a.m. Aug. 20, 2014 - BusinessWire - BZX
Pernix Therapeutics Reports Second Quarter 2014 Financial Results 7:31 a.m. Aug. 11, 2014 - BusinessWire - BZX
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Closing for Pernix Transaction to Acquire Treximet® Tablets for Migraine from GSK Delayed 8:15 a.m. Aug. 4, 2014 - BusinessWire - BZX
Pernix Therapeutics to Report Second Quarter 2014 Financial Results on August 11, 2014 8:01 a.m. July 25, 2014 - BusinessWire - BZX
Gyrotron Technology Inc. Elects Jan H. Loeb to Its Board of Directors 2:11 p.m. July 22, 2014 - Marketwire
Agreements, Orphan Drug Designations, and Management Changes - Analyst Notes on Medtronic, DARA BioSciences, Sequenom, AcelRx and Pernix 4:20 a.m. June 19, 2014 - PR Newswire - PRF
Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma 6:10 a.m. June 16, 2014 - PR Newswire - PRF
Technical Analysis on Equities Reaching New Highs -- Research on Kroger, SBA Communications, SunOpta, and Pernix Therapeutics 9:43 a.m. May 15, 2014 - PR Newswire - PRF
PERNIX Signs Agreement to Acquire TREXIMET® Tablets for Migraine From GSK 6:31 a.m. May 14, 2014 - BusinessWire - BZX
POZEN Announces U.S. Rights for Treximet® to Be Acquired by Pernix Therapeutics 6:31 a.m. May 14, 2014 - BusinessWire - BZX
Pernix Therapeutics to Report First Quarter 2014 Financial Results on May 12, 2014 8:06 a.m. May 12, 2014 - BusinessWire - BZX
Pernix Therapeutics Reports First Quarter 2014 Financial Results 7:32 a.m. May 12, 2014 - BusinessWire - BZX
Pernix Therapeutics Appoints Tasos Konidaris to Its Board of Directors 7:46 a.m. April 28, 2014 - BusinessWire - BZX
Pernix Closes on Sale of Manufacturing Facility 7:46 a.m. April 25, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼